Linda Noskova vs Anastasia Gasanova

WTA Prague 1st Round Preview: Linda Noskova vs Anastasia Gasanova

🧠 Form & Context

Linda Noskova
💫 Home spotlight: Noskova returns to Prague as the top Czech hope with an impressive track record—semifinalist in 2022 and 2024, finalist in 2023.
🎾 Hard court solid: Her 9–8 hard-court record in 2025 includes R3 runs in Rome, Madrid, and a strong semifinal showing in Abu Dhabi.
🌱 Grass swing surge: Recently reached the QF in Nottingham and R4 at Wimbledon, beating Pera, Lys, and Rakhimova before a close loss to Anisimova.
📈 Top 25 rise: Ranked No. 23, Noskova has been a steady presence at the WTA level this year with a 21–17 overall record.

Anastasia Gasanova
🧱 ITF powerhouse: A veteran of the lower circuits, Gasanova owns a 35–13 record in 2025—though almost entirely at ITF level.
🚀 Momentum: She’s won 22 of her last 26 matches, including back-to-back ITF finals in Bol and a successful qualification campaign in Prague.
⚖️ Step up in class: Ranked No. 249, Gasanova hasn’t defeated a Top 50 player since 2022 and hasn’t won a WTA main draw match in 18 months.
📍 Past in Prague: Made R16 here in 2021, now back in a WTA main draw for the first time since Hamburg 2024.

🔍 Match Breakdown

This matchup is a textbook example of elite-level firepower meeting ITF-level consistency. Noskova thrives on medium-fast hard courts, particularly at home, where she’s produced her best tennis. Her aggressive return game and forehand dominance make her dangerous in any setting—more so with crowd backing.

Gasanova, while red-hot at the ITF level, has struggled historically to translate that to the WTA stage. She doesn’t possess the same weight of shot and will need to rely on defensive depth and rally tolerance to stay competitive. Noskova’s clean ball-striking and home rhythm should dictate proceedings unless nerves creep in early.

🔮 Prediction

Prediction: Noskova in straight sets
Gasanova’s recent win streak may give her confidence, but Noskova’s ceiling and familiarity with this venue suggest a composed and clinical performance is likely.